BiPAP (Bilevel Positive Airway Pressure) is an electronic breathing device used in the treatment of sleep apnea, lung disease, and to treat respiratory weakness.
Also known as NIPPV, use of the device overnight improves quality of sleep, daytime sleepiness, and may improve thinking ability.
Nowadays, COVID-19 which caused by the novel coronavirus outbreak worldwide.
The virus will quickly invade human lung cells and cause pneumonia, which will cause severe lower respiratory tract diseases, such as acute lung injury and respiratory distress syndrome.
Some critical patient may even have symptoms such as respiratory failure, refractory hypoxemia, shock, multiple organ failure, and coagulopathy.
For COVID-19, ventilator is one of the most effective treatments in the absence of specific drugs. Under ventilated, the blood oxygen of patient can be effectively improved and the mortality rate can be reduced.
B-30P can be used in para treatment for patients with COVID-19.
Features:
Small size, color LCD display
Portable and easy to operate
Can be equipped with trolleys
Can be equipped with independent humidifier
Can be equipped with SPO2 module
Real-time display and monitoring of clinical use data of patients;
Connect to Low-flow oxygen, for air-oxygen mixing;
With VAF (Vital assurance function);
Using environments:
Early intervention for respiratory failure for patients with COVID-19;
After extubating, when the patient is removed from the invasive ventilator and transferred to a non-invasive ventilator.
Applications:
The patient has a certain ability to breathe spontaneously and is in good condition, or applied when transferred to a general ward.